StockData

Addex Therapeutics vs Jupiter Neurosciences

ADXN and JUNS side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricADXNJUNS
Size and price
Market cap–$1.3M
Share price$3.83$1.70
Change, 1 year−55.5%−98.3%
Change, 5 years−97.3%–
Beta (5Y)1.84−0.18
Employees35
StockData Score
Total score00
Valuation score00
Growth score00
Performance score00
Health score00
Dividend score00
Growth
Revenue growth (TTM)−92.6%–
Revenue growth, 5Y average−61.6%–
EPS growth (TTM)−186%–
Profitability
Operating margin−9391%–
FCF margin−7244%–
Return on equity–−1889%
Financial health
Interest coverage−181.0×−36.0× (better)
Current ratio0.76 (better)0.66
Altman Z-score–−23.63
Piotroski F-score–3
Dividends and buybacks
Shareholder yield–0.00%
Ownership
Held by institutions0.00%2.2%
Held by insiders15.5%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.